RTI Surgical, Inc. (RTIX) Lifted to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of RTI Surgical, Inc. (NASDAQ:RTIX) from a sell rating to a hold rating in a research report sent to investors on Thursday, May 11th.

According to Zacks, “RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla. “

Separately, TheStreet upgraded shares of RTI Surgical from a d+ rating to a c- rating in a research report on Friday, May 5th.

Shares of RTI Surgical (NASDAQ:RTIX) opened at 5.30 on Thursday. RTI Surgical has a 12-month low of $2.50 and a 12-month high of $5.35. The stock’s market capitalization is $308.07 million. The stock’s 50 day moving average is $4.90 and its 200-day moving average is $3.86.

RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Thursday, April 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter. RTI Surgical had a negative net margin of 6.85% and a positive return on equity of 1.34%. The company had revenue of $69.90 million for the quarter, compared to analyst estimates of $67.68 million. During the same quarter in the prior year, the business earned $0.03 earnings per share. RTI Surgical’s revenue was up 3.7% on a year-over-year basis. On average, analysts expect that RTI Surgical will post $0.08 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “RTI Surgical, Inc. (RTIX) Lifted to Hold at Zacks Investment Research” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/06/17/rti-surgical-inc-rtix-upgraded-at-zacks-investment-research-updated-updated-updated.html.

In other RTI Surgical news, EVP Kevin D. Brandt acquired 33,130 shares of the stock in a transaction dated Wednesday, May 3rd. The stock was acquired at an average price of $4.52 per share, with a total value of $149,747.60. Following the completion of the purchase, the executive vice president now owns 126,215 shares in the company, valued at approximately $570,491.80. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Nicholas J. Valeriani acquired 5,500 shares of the stock in a transaction dated Thursday, May 4th. The stock was acquired at an average cost of $4.60 per share, with a total value of $25,300.00. Following the purchase, the director now owns 25,770 shares of the company’s stock, valued at approximately $118,542. The disclosure for this purchase can be found here. In the last three months, insiders bought 112,023 shares of company stock valued at $514,421. Insiders own 4.90% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. SECOR Capital Advisors LP increased its position in shares of RTI Surgical by 3.4% in the third quarter. SECOR Capital Advisors LP now owns 112,292 shares of the medical equipment provider’s stock worth $351,000 after buying an additional 3,702 shares in the last quarter. State Street Corp increased its position in shares of RTI Surgical by 2.6% in the fourth quarter. State Street Corp now owns 996,778 shares of the medical equipment provider’s stock worth $3,243,000 after buying an additional 25,581 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of RTI Surgical by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,825,098 shares of the medical equipment provider’s stock worth $12,432,000 after buying an additional 10,573 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of RTI Surgical by 28.9% in the fourth quarter. Renaissance Technologies LLC now owns 674,200 shares of the medical equipment provider’s stock worth $2,191,000 after buying an additional 151,200 shares in the last quarter. Finally, Menta Capital LLC increased its position in shares of RTI Surgical by 84.7% in the fourth quarter. Menta Capital LLC now owns 115,708 shares of the medical equipment provider’s stock worth $376,000 after buying an additional 53,067 shares in the last quarter. Institutional investors own 77.03% of the company’s stock.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

What are top analysts saying about RTI Surgical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RTI Surgical Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit